🧬
CRISPRO
.AI
HOME
RECEIPTS
SAFETY
ORG
ENGINES
A+
CONFIRM CERTAINTY
NAVIGATE
HOME
SAFETY
ORG · CRISPRO.ORG
RECEIPTS · TRIAL CASES
LATIFY
BRAF V600E CRC · MoA failure analysis
CEACAM5
Tusamitamab ADC · antigen expression gate
ADAVOSERTIB
WEE1i · DNA-damage SL window
CAPRI
Ceralasertib · ATR MBD4-LOF SL proof
BERZOSERTIB
ATR inhibitor · replication stress gate
ENGINES
TARGET-LOCK
AUC 0.822
MECHANISM ALIGNMENT
8D Vector
KILL CHAIN
AUROC 0.783
IO RISK-BENEFIT GATE
NCB Active
SYNTHETIC LETHALITY
d = −0.88
SAFETY & DOSING
100% CPIC
PREDICTION IS
CERTAINTY
.
ACTIVE GATE
_
FIVE PHASE III FAILURES. FIVE RECEIPTS. ZERO EXCUSES.
SEE THE RECEIPTS
TALK TO US
ORACLE
MATRIX
CEACAM5
LATIFY
ADAVOSERTIB
CAPRI
BERZOSERTIB
01/07